5.7(top 5%)
impact factor
2.5K(top 10%)
papers
74.1K(top 5%)
citations
97(top 5%)
h-index
6.1(top 5%)
impact factor
2.9K
all documents
78.1K
doc citations
136(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Mechanisms of resistance to TRAIL-induced apoptosis in cancerCancer Gene Therapy2005617
2Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigmsCancer Gene Therapy2021444
3Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanomaCancer Gene Therapy1999324
4The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectinCancer Gene Therapy2006313
5siRNA-based approaches in cancer therapyCancer Gene Therapy2006308
6MicroRNA and drug resistanceCancer Gene Therapy2010281
7Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patientsCancer Gene Therapy2003277
8MicroRNA profile analysis of human prostate cancersCancer Gene Therapy2009251
9Role of anti-oncomirs miR-143 and -145 in human colorectal tumorsCancer Gene Therapy2010251
10Intravascular adenoviral agents in cancer patients: Lessons from clinical trialsCancer Gene Therapy2002236
11Oncolytic herpes simplex virus vectors for cancer virotherapyCancer Gene Therapy2002235
12Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?Cancer Gene Therapy2008230
13A comparison of gene transfer methods in human dendritic cellsCancer Gene Therapy1997227
14Bifidobacterium longum as a delivery system for cancer gene therapy: Selective localization and growth in hypoxic tumorsCancer Gene Therapy2000213
15Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growthCancer Gene Therapy2009209
16The ERBB3 receptor in cancer and cancer gene therapyCancer Gene Therapy2008204
17Glioblastoma: exosome and microRNA as novel diagnosis biomarkersCancer Gene Therapy2016203
18Drug sensitivity ("suicide") genes for selective cancer chemotherapyCancer Gene Therapy1994202
19Key chemokines direct migration of immune cells in solid tumorsCancer Gene Therapy2022186
20Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cellsCancer Gene Therapy2004176
21Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNACancer Gene Therapy2006176
22Short interfering RNAs as a tool for cancer gene therapyCancer Gene Therapy2005175
23Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancerCancer Gene Therapy2017175
24Suppression of growth and transformation and induction of apoptosis by EGR-1Cancer Gene Therapy1998175
25Development and application of adenoviral vectors for gene therapy of cancerCancer Gene Therapy1999173
26A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancerCancer Gene Therapy2002171
27Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX® vaccine in advanced-stage non-small-cell lung cancerCancer Gene Therapy2006165
28Cancer-associated fibroblasts: overview, progress, challenges, and directionsCancer Gene Therapy2021165
29High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirusCancer Gene Therapy1994164
30Prospects for CD40-directed experimental therapy of human cancerCancer Gene Therapy2003160
31CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivoCancer Gene Therapy2005160
32Viral vector systems for gene therapyCancer Gene Therapy1994157
33Nanovector delivery of siRNA for cancer therapyCancer Gene Therapy2012156
34New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticlesCancer Gene Therapy2017155
35Vaccinia as a vector for tumor-directed gene therapy: Biodistribution of a thymidine kinase-deleted mutantCancer Gene Therapy2000152
36Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotidesCancer Gene Therapy2000151
37Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivoCancer Gene Therapy2005151
38Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapiesCancer Gene Therapy2011151
39Towards a commercial process for the manufacture of genetically modified T cells for therapyCancer Gene Therapy2015151
40Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cellsCancer Gene Therapy2007150
41Heat-inducible TNF-α gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapyCancer Gene Therapy2001146
42MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancerCancer Gene Therapy2017146
43Targeting of adenoviral vectors through a bispecific single-chain antibodyCancer Gene Therapy2000145
44Transcription factors in ferroptotic cell deathCancer Gene Therapy2020141
45Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccineCancer Gene Therapy2006140
46mRNA-based cancer vaccine: prevention of B16 melanoma progression and metastasis by systemic injection of MART1 mRNA histidylated lipopolyplexesCancer Gene Therapy2007140
47Recent advances in p53 research: an interdisciplinary perspectiveCancer Gene Therapy2009140
48RNA viruses as virotherapy agentsCancer Gene Therapy2002139
49Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patientsCancer Gene Therapy2009139
50Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumorsCancer Gene Therapy2007135